These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20393871)

  • 1. Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats.
    Wu X; Zong Y; Ye Z; Lu ZR
    Pharm Res; 2010 Jul; 27(7):1390-7. PubMed ID: 20393871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
    Wang X; Feng Y; Ke T; Schabel M; Lu ZR
    Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced magnetic resonance angiography with biodegradable (Gd-DTPA)-cystamine copolymers: comparison with MS-325 in a swine model.
    Nguyen TD; Spincemaille P; Vaidya A; Prince MR; Lu ZR; Wang Y
    Mol Pharm; 2006; 3(5):558-65. PubMed ID: 17009855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
    Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
    Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.
    Feng Y; Emerson L; Jeong EK; Parker DL; Lu ZR
    J Magn Reson Imaging; 2009 Aug; 30(2):401-6. PubMed ID: 19629979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
    Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.
    Zong Y; Wang X; Goodrich KC; Mohs AM; Parker DL; Lu ZR
    Magn Reson Med; 2005 Apr; 53(4):835-42. PubMed ID: 15799038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates?
    Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R
    Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.
    Laurent S; Elst LV; Muller RN
    Contrast Media Mol Imaging; 2006; 1(3):128-37. PubMed ID: 17193689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice.
    Wu X; Feng Y; Jeong EK; Emerson L; Lu ZR
    Pharm Res; 2009 Sep; 26(9):2202-8. PubMed ID: 19597972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
    Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
    Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model.
    Feng Y; Zong Y; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Aug; 23(8):1736-42. PubMed ID: 16850267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.
    Wu X; Jeong EK; Emerson L; Hoffman J; Parker DL; Lu ZR
    Mol Pharm; 2010 Feb; 7(1):41-8. PubMed ID: 19958031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
    Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media.
    Puttagunta NR; Gibby WA; Puttagunta VL
    Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging.
    Ke T; Feng Y; Guo J; Parker DL; Lu ZR
    Magn Reson Imaging; 2006 Sep; 24(7):931-40. PubMed ID: 16916710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
    McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
    J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rates of the exchange reactions between [Gd(DTPA)]2- and the endogenous ions Cu2+ and Zn2+: a kinetic model for the prediction of the in vivo stability of [Gd(DTPA)]2-, used as a contrast agent in magnetic resonance imaging.
    Sarka L; Burai L; Brücher E
    Chemistry; 2000 Feb; 6(4):719-24. PubMed ID: 10807182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of nanoglobule-cystamine-(Gd-DO3A), a biodegradable nanosized magnetic resonance contrast agent for dynamic contrast-enhanced magnetic resonance urography.
    Xu R; Kaneshiro TL; Jeong EK; Parker DL; Lu ZR
    Int J Nanomedicine; 2010 Sep; 5():707-13. PubMed ID: 20957222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.